These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26586486)

  • 21. Immune-Mediated Myopathies.
    Goyal NA
    Continuum (Minneap Minn); 2019 Dec; 25(6):1564-1585. PubMed ID: 31794460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.
    Dalakas MC
    Acta Myol; 2020 Dec; 39(4):289-301. PubMed ID: 33458584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification and management of adult inflammatory myopathies.
    Selva-O'Callaghan A; Pinal-Fernandez I; Trallero-Araguás E; Milisenda JC; Grau-Junyent JM; Mammen AL
    Lancet Neurol; 2018 Sep; 17(9):816-828. PubMed ID: 30129477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Idiopathic inflammatory myopathies].
    Vencovský J
    Vnitr Lek; 2018; 64(2):155-163. PubMed ID: 29595280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory myopathies.
    Amato AA; Greenberg SA
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory muscle diseases.
    Mastaglia FL
    Neurol India; 2008; 56(3):263-70. PubMed ID: 18974552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of inflammatory myopathies.
    Mastaglia FL; Laing BA; Zilko P
    Baillieres Clin Neurol; 1993 Nov; 2(3):717-40. PubMed ID: 8156149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
    Kostine M; Finckh A; Bingham CO; Visser K; Leipe J; Schulze-Koops H; Choy EH; Benesova K; Radstake TRDJ; Cope AP; Lambotte O; Gottenberg JE; Allenbach Y; Visser M; Rusthoven C; Thomasen L; Jamal S; Marabelle A; Larkin J; Haanen JBAG; Calabrese LH; Mariette X; Schaeverbeke T
    Ann Rheum Dis; 2021 Jan; 80(1):36-48. PubMed ID: 32327425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory myopathies: A new landscape.
    Meyer A; Lannes B; Goetz J; Echaniz-Laguna A; Lipsker D; Arnaud L; Martin T; Gottenberg JE; Geny B; Sibilia J
    Joint Bone Spine; 2018 Jan; 85(1):23-33. PubMed ID: 28343013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the pharmacological treatment of adult myositis.
    Oddis CV
    J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory myopathies: shedding light on promising agents and combination therapies in clinical trials.
    Zeng R; Glaubitz S; Schmidt J
    Expert Opin Investig Drugs; 2021 Nov; 30(11):1125-1140. PubMed ID: 34779311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on treatment of inclusion body myositis.
    Breithaupt M; Schmidt J
    Curr Rheumatol Rep; 2013 May; 15(5):329. PubMed ID: 23529584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dysimmune and inflammatory myopathies].
    Authier FJ
    Rev Prat; 2008 Dec; 58(20):2253-60. PubMed ID: 19209656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous human immunoglobulin for the treatment of recurrent focal myositis.
    Santos-Faria D; Sousa-Neves J; Leite Silva J; Ramos Rodrigues J; Azevedo S; Alcino S; Afonso C; Teixeira F
    Acta Reumatol Port; 2019; 44(1):88-89. PubMed ID: 31249282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
    Inoue M; Nishino I
    Brain Nerve; 2016 Dec; 68(12):1431-1441. PubMed ID: 27916753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to diagnose and treat the inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 1994 Jun; 14(2):137-45. PubMed ID: 7984828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential therapeutic targets for idiopathic inflammatory myopathies.
    De Bleecker JL; Creus KK; De Paepe B
    Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.